Filter
16
Filtered Results: 16
Text search:
genetically
engineered
plants
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
6
Manuals
4
Studies & Reports
3
Guidelines
2
Fact sheets
1
Countries / Regions
India
2
Kenya
1
Nigeria
1
Philippines
1
Global
1
Uganda
1
Authors & Publishers
Publication Years
Category
Guidelines
3
General Guidelines
2
Sanitation
1
Disaster Preparedness
1
Community Health
1
NCD
1
Policies & Guidelines HIV & TB
1
Policies
1
Drugs & Medical Equipment
1
Studies & Reports
1
Statistics
1
WASH
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Water
1
Hygiene Promotion
1
Toolboxes
Laboratory Guidance
4
Diagnostics & Laboratory Guidance
2
Rapid Response
1
Biosafety
1
Preparedness, Response & Risk Communication
1
Laboratory & Sampling
1
Global Impact: Socio-economic, health services, TB & HIV
1
Essential Medicines & Medical Devices
1
Health Promotion
1
Land-system change
1
General documents One Health
1
Climate Change
1
Environment
1
Clinical Aspects & Diagnosis
1
One Health
1
WASH
1
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood that many changes will become necessary and will be incorporated as we progress. This document will ho...
With hundreds of illustrations and clear instructions, A Community Guide to Environmental Health helps health promoters, development workers, environmental activists, and community leaders take charge of their environmental health in villages and cities alike. Also available in Arabic, Spanish, Chin...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
Doc. No.: INS/GDL/001-(Annexes)
Healthy people, healthy animals and a healthy environment worldwide with the One Health approach.
The COVID-19 pandemic has drastically demonstrated just how close the link is between humans, animals, and the environment, and has highlighted and aggravated existing challenges. The destruction of na...
Laboratory Biossafety Manual
Human use of land has been transforming Earth's ecology for millennia. From hunting and foraging to burning the land to farming to industrial agriculture, increasingly intensive human use of land has reshaped global patterns of biodiversity, ecosystems, landscapes, and climate. This review examines ...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
